te

Bio-Techne

TECH
NASDAQ
$72.36

Bio-Techne est-elle financièrement solide ?

Bio-Techne has an exceptionally strong balance sheet with low leverage. The company could comfortably weather a severe economic downturn. This financial fortress provides strategic flexibility and reduces risk for long-term shareholders.